4//SEC Filing
MERRIMACK PHARMACEUTICALS INC 4
Accession 0001179110-15-005436
CIK 0001274792operating
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 5:26 PM ET
Size
23.8 KB
Accession
0001179110-15-005436
Insider Transaction Report
Form 4
Mulroy Robert J.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2015-03-23$11.69/sh−10,400$121,576→ 1,339,316 total - Exercise/Conversion
Common Stock
2015-03-24$2.59/sh+26,689$69,125→ 1,588,990 total - Exercise/Conversion
Stock Option (right to buy)
2015-03-24−273,968→ 0 totalExercise: $1.71Exp: 2015-08-03→ Common Stock (273,968 underlying) - Sale
Common Stock
2015-03-24$11.71/sh−103,968$1,217,465→ 1,509,316 total - Exercise/Conversion
Common Stock
2015-03-23$1.71/sh+10,400$17,784→ 1,349,716 total - Exercise/Conversion
Common Stock
2015-03-24$1.71/sh+273,968$468,485→ 1,613,284 total - Exercise/Conversion
Common Stock
2015-03-24$2.12/sh+94,338$199,997→ 1,683,328 total - Exercise/Conversion
Stock Option (right to buy)
2015-03-24−52,985→ 0 totalExercise: $2.47Exp: 2017-01-23→ Common Stock (52,985 underlying) - Exercise/Conversion
Stock Option (right to buy)
2015-03-24−94,338→ 680,662 totalExercise: $2.12Exp: 2019-11-05→ Common Stock (94,338 underlying) - Exercise/Conversion
Stock Option (right to buy)
2015-03-24−26,689→ 0 totalExercise: $2.59Exp: 2017-10-04→ Common Stock (26,689 underlying) - Exercise/Conversion
Common Stock
2015-03-24$2.47/sh+52,985$130,873→ 1,562,301 total - Exercise/Conversion
Stock Option (right to buy)
2015-03-23−10,400→ 273,968 totalExercise: $1.71Exp: 2015-08-03→ Common Stock (10,400 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.65 to $11.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.50 to $11.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F3]This option is fully vested.
Documents
Issuer
MERRIMACK PHARMACEUTICALS INC
CIK 0001274792
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001274792
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 5:26 PM ET
- Size
- 23.8 KB